204 related articles for article (PubMed ID: 24594996)
1. CD74: a new prognostic factor for patients with malignant pleural mesothelioma.
Otterstrom C; Soltermann A; Opitz I; Felley-Bosco E; Weder W; Stahel RA; Triponez F; Robert JH; Serre-Beinier V
Br J Cancer; 2014 Apr; 110(8):2040-6. PubMed ID: 24594996
[TBL] [Abstract][Full Text] [Related]
2. Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma.
D'Amato-Brito C; Cipriano D; Colin DJ; Germain S; Seimbille Y; Robert JH; Triponez F; Serre-Beinier V
Oncotarget; 2016 Mar; 7(10):11512-25. PubMed ID: 26883190
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
Ekmekcioglu S; Davies MA; Tanese K; Roszik J; Shin-Sim M; Bassett RL; Milton DR; Woodman SE; Prieto VG; Gershenwald JE; Morton DL; Hoon DS; Grimm EA
Clin Cancer Res; 2016 Jun; 22(12):3016-24. PubMed ID: 26783288
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
Schramm A; Opitz I; Thies S; Seifert B; Moch H; Weder W; Soltermann A
Eur J Cardiothorac Surg; 2010 Mar; 37(3):566-72. PubMed ID: 19781955
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
6. Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
Verjans E; Noetzel E; Bektas N; Schütz AK; Lue H; Lennartz B; Hartmann A; Dahl E; Bernhagen J
BMC Cancer; 2009 Jul; 9():230. PubMed ID: 19602265
[TBL] [Abstract][Full Text] [Related]
7. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
[TBL] [Abstract][Full Text] [Related]
8. A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide.
Lapter S; Ben-David H; Sharabi A; Zinger H; Telerman A; Gordin M; Leng L; Bucala R; Shachar I; Mozes E
Immunology; 2011 Jan; 132(1):87-95. PubMed ID: 20738420
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.
McClelland M; Zhao L; Carskadon S; Arenberg D
Am J Pathol; 2009 Feb; 174(2):638-46. PubMed ID: 19131591
[TBL] [Abstract][Full Text] [Related]
10. Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.
Thapa B; Walkiewicz M; Murone C; Asadi K; Deb S; Barnett S; Knight S; Mitchell P; Liew D; Watkins DN; John T
Pathology; 2016 Dec; 48(7):660-665. PubMed ID: 27780599
[TBL] [Abstract][Full Text] [Related]
11. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
[TBL] [Abstract][Full Text] [Related]
12. Improved survival of mesenchymal stem cells by macrophage migration inhibitory factor.
Xia W; Xie C; Jiang M; Hou M
Mol Cell Biochem; 2015 Jun; 404(1-2):11-24. PubMed ID: 25701358
[TBL] [Abstract][Full Text] [Related]
13. Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.
Marsh LM; Cakarova L; Kwapiszewska G; von Wulffen W; Herold S; Seeger W; Lohmeyer J
Am J Physiol Lung Cell Mol Physiol; 2009 Mar; 296(3):L442-52. PubMed ID: 19136583
[TBL] [Abstract][Full Text] [Related]
14. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
15. MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.
Pasello G; Urso L; Mencoboni M; Grosso F; Ceresoli GL; Lunardi F; Vuljan SE; Bertorelle R; Sacchetto V; Ciminale V; Rea F; Favaretto A; Conte P; Calabrese F
Oncotarget; 2015 Dec; 6(39):42053-66. PubMed ID: 26544728
[TBL] [Abstract][Full Text] [Related]
16. CD74 expression and its therapeutic potential in thyroid carcinoma.
Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
[TBL] [Abstract][Full Text] [Related]
17. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.
Cheng RJ; Deng WG; Niu CB; Li YY; Fu Y
Int J Gynecol Cancer; 2011 Aug; 21(6):1004-12. PubMed ID: 21792010
[TBL] [Abstract][Full Text] [Related]
18. Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.
Cedrés S; Montero MA; Zamora E; Martínez A; Martínez P; Fariñas L; Navarro A; Torrejon D; Gabaldon A; Ramon Y Cajal S; Felip E
Clin Transl Oncol; 2014 Sep; 16(9):776-82. PubMed ID: 24323466
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.
Heinrichs D; Knauel M; Offermanns C; Berres ML; Nellen A; Leng L; Schmitz P; Bucala R; Trautwein C; Weber C; Bernhagen J; Wasmuth HE
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17444-9. PubMed ID: 21969590
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
